ABVC - Company ID 0001173313
ABVC BIOPHARMA, INC. (ABVC) reported net income of -$7.91M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$7.91M | -61.3% |
| FY 2024 | -$4.90M | +37.0% |
| FY 2023 | -$7.79M | +52.6% |
| FY 2022 | -$16.42M | -27.9% |
| FY 2021 | -$12.84M | -21.2% |
| FY 2020 | -$10.59M | -169.3% |
| FY 2019 | -$3.93M | +35.1% |
| FY 2018 | -$6.06M | -42.9% |
| FY 2017 |
ABVC BIOPHARMA, INC. (ABVC) reported net income of -$7.91M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2011 and fiscal 2025, ABVC BIOPHARMA, INC.'s net income declined from -$1.22M to -$7.91M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| -$4.24M |
| +61.5% |
| FY 2016 | -$11.01M | -33999.9% |
| FY 2015 | -$32.28K | -38.9% |
| FY 2014 | -$23.23K | +89.7% |
| FY 2013 | -$226.35K | +78.8% |
| FY 2012 | -$1.07M | +12.2% |
| FY 2011 | -$1.22M | - |